ELI LILLY & Co is 296.3x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $3.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRNX | LLY |
|---|---|---|
| Market cap | $3.62 B | $1.072 T |
| US-listed rank | #1659 | #10 |
| Revenue (latest FY) | $7.70M | $65.18B |
| Net income (latest FY) | -$465.30M | $20.64B |
| Net margin | -6046.0% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 670 | 989 |
ELI LILLY & Co is 296.3x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($1.072 T vs $3.62 B).
In their latest fiscal years, Crinetics Pharmaceuticals, Inc. reported $7.70M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Crinetics Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.